HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Intracranial Electrode Stimulation

Intracranial Electrode Stimulation

Intracranial electrode stimulation, also known as neuromodulation, is a type of medical procedure that is gaining increasing attention for its potential to treat a variety of neurological disorders. In this treatment, electrodes are surgically placed within or on top of the brain and used to deliver electrical stimulation to specific areas of the brain. This stimulation can be programmed to adapt to the patient’s needs, and is thought to modulate abnormal electrical activity in the brain with the ultimate goal of controlling or relieving symptoms associated with their condition. The types of disorders that can be treated with intracranial electrode stimulation vary depending on the patient and the origin of their disorder. Some of these conditions include movement disorders such as Parkinson’s disease, epilepsy, depression, obsessive-compulsive disorder, psychosis, schizophrenia, and post-traumatic stress. Neuromodulation is also being studied for use in treating pain and addiction. The procedure involves surgically implanting electrodes in or on the brain that are linked to a small electronic device under the skin on the chest. This device can be programmed to send electrical pulses to the brain at specific frequencies, which helps to modulate neural activity and reduce the symptoms associated with the patient’s condition. Depending on the individual needs of the patient, additional external devices may also be used to help control and monitor the stimulation levels. Given its potential to help treat a variety of neurological disorders, intracranial electrode stimulation is quickly becoming a popular option for many patients. Further research is still needed to expand the understanding of this treatment, including investigating optimal dosages, durations, and stimulation levels. However, this technique has already been found to be relatively safe and well tolerated, offering patients a new hope for symptom relief.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
Tags

Submit your abstract Today

Watsapp